TREM-1 and TREM-2 Expression on CD14+ Cells in Bronchoalveolar Lavage Fluid in Pulmonary Sarcoidosis and Hypersensitivity Pneumonitis in the Context of T Cell Immune Response

<div>(a) Decrease in percentage of TREM-1+ CD14+ cells. (b) Decrease in percentage of CD4+ T cells. (c) Increase in percentage of CD8+ T cells. (d) Decrease in diffusing capacity of lungs for carbon monoxide (DLCO) in relationship with HRCT changes acquired from type Ia to type IIb. Ia-hilar and mediastinal lymphadenopathy with no pulmonary infiltrates; Ib-hilar and mediastinal lymphadenopathy and solitary nodules; IIa-hilar and mediastinal lymfadenopathy and numerous small pulmonary nodules building clusters in typical areas for sarcoidosis; IIb-hilar and mediastinal lymphadenopathy and pulmonary infiltrates or ground glass opacity.</div>

Mediators of Inflammation

fig2

Figure 2

Figure 2: TREM-1 and TREM-2 Expression on CD14+ Cells in Bronchoalveolar Lavage Fluid in Pulmonary Sarcoidosis and Hypersensitivity Pneumonitis in the Context of T Cell Immune Response

Figure 2 | TREM-1 and TREM-2 Expression on CD14+ Cells in Bronchoalveolar Lavage Fluid in Pulmonary Sarcoidosis and Hypersensitivity Pneumonitis in the Context of T Cell Immune Response 